225 results on '"Sheehan, Christine E."'
Search Results
2. Figure S3(A-C) from Dual Targeting of EGFR and IGF1R in the TNFAIP8 Knockdown Non–Small Cell Lung Cancer Cells
3. Data from Dual Targeting of EGFR and IGF1R in the TNFAIP8 Knockdown Non–Small Cell Lung Cancer Cells
4. Figure S2 from Dual Targeting of EGFR and IGF1R in the TNFAIP8 Knockdown Non–Small Cell Lung Cancer Cells
5. Figure S4 (A,B) from Dual Targeting of EGFR and IGF1R in the TNFAIP8 Knockdown Non–Small Cell Lung Cancer Cells
6. Supplementary materials from Dual Targeting of EGFR and IGF1R in the TNFAIP8 Knockdown Non–Small Cell Lung Cancer Cells
7. Supplementary Table 1 from A High Frequency of Activating Extracellular Domain ERBB2 (HER2) Mutation in Micropapillary Urothelial Carcinoma
8. Supplementary Table S1. from Relapsed Classic E-Cadherin (CDH1)–Mutated Invasive Lobular Breast Cancer Shows a High Frequency of HER2 (ERBB2) Gene Mutations
9. Supplementary Data from Relapsed Classic E-Cadherin (CDH1)–Mutated Invasive Lobular Breast Cancer Shows a High Frequency of HER2 (ERBB2) Gene Mutations
10. Supplementary Figure 1 from A High Frequency of Activating Extracellular Domain ERBB2 (HER2) Mutation in Micropapillary Urothelial Carcinoma
11. Supplementary Data from The Proapoptotic Molecule BLID Interacts with Bcl-XL and Its Downregulation in Breast Cancer Correlates with Poor Disease-Free and Overall Survival
12. Novel Finding of Paired Box 5 (PAX5) Cytoplasmic Staining in Well-differentiated Rectal Neuroendocrine Tumors (Carcinoids) and Its Diagnostic and Potentially Prognostic Utility
13. Comprehensive genomic profiling of malignant phyllodes tumors of the breast
14. Advanced urothelial carcinoma: next-generation sequencing reveals diverse genomic alterations and targets of therapy
15. Paired Box 5 (PAX5) Expression in Poorly Differentiated Neuroendocrine Carcinoma of the Gastrointestinal and Pancreatobiliary Tract: Diagnostic and Potentially Therapeutic Implications
16. Collaborative Multi-institutional Experience in Comparing PD-L1 Immunohistochemistry Assays: Concordance of SP142 and 22C3 Immunoreactivity
17. PD-L1 protein expression in tumour cells and immune cells in mismatch repair protein-deficient and -proficient colorectal cancer: the foundation study using the SP142 antibody and whole section immunohistochemistry
18. Next-Generation Sequencing Reveals Pathway Activations and New Routes to Targeted Therapies in Cutaneous Metastatic Melanoma
19. Histological Spectrum of Idiopathic Noncirrhotic Portal Hypertension in Liver Biopsies From Dialysis Patients
20. Prostate-specific membrane antigen expression in the neovasculature of gastric and colorectal cancers
21. Clinical next-generation sequencing successfully applied to fine-needle aspirations of pulmonary and pancreatic neoplasms
22. Survivin and Bcl-2 expression in prostatic Adenocarcinomas
23. The significance of TNFAIP8 in prostate cancer response to radiation and docetaxel and disease recurrence
24. Identification of new ALK and RET gene fusions from colorectal and lung cancer biopsies
25. Overexpression of WWP1 is associated with the estrogen receptor and insulin-like growth factor receptor 1 in breast carcinoma
26. Follicular carcinoma associated with minocycline-induced black thyroid
27. Hyaluronan Accumulation in Thyroid Tissue: Evidence for Contributions from Epithelial Cells and Fibroblasts
28. Co-downregulation of PTEN, KAI-1, and nm23-H1 tumor/metastasis suppressor proteins in non-small cell lung cancer
29. Delivery of IL-12 intranasally leads to reduced IL-12-mediated toxicity
30. Genomic Profiling of Advanced-Stage, Metaplastic Breast Carcinoma by Next-Generation Sequencing Reveals Frequent, Targetable Genomic Abnormalities and Potential New Treatment Options
31. Prognostic Significance of Matrix Metalloproteinase 2 and Tissue Inhibitor of Metalloproteinase 2 Expression in Prostate Cancer
32. Decreased expression of catenins (alpha and beta), p120 CTN, and E-cadherin cell adhesion proteins and E-cadherin gene promoter methylation in prostatic adenocarcinomas
33. Prognostic Significance of p34cdc2 Cyclin-Dependent Kinase and MIB1 Overexpression, and HER-2/neu Gene Amplification Detected by Fluorescence In Situ Hybridization in Breast Cancer
34. HER-2/neu Oncogene Amplification by Fluorescence In Situ Hybridization in Epithelial Tumors of the Ovary
35. Dual Targeting of EGFR and IGF1R in the TNFAIP8 Knockdown Non–Small Cell Lung Cancer Cells
36. The prognostic significance of proliferation-associated nucleolar protein p120 expression in prostate adenocarcinoma: a comparison with cyclins A and B1, Ki-67, proliferating cell nuclear antigen, and p34(super)cdc2
37. Epigenetic regulator MLL2 shows altered expression in cancer cell lines and tumors from human breast and colon
38. Cell Proliferation Rate by MIB-1 Immunohistochemistry Predicts Postradiation Recurrence in Prostatic Adenocarcinomas
39. A pilot study to evaluate the effectiveness of small intestinal submucosa used to repair spinal ligaments in the goat
40. The prognostic significance of p34(super cdc2) and cyclin D1 protein expression in prostate adenocarcinoma
41. Prognostic significance of HER-2/neu gene amplification status by fluorescence in situ hybridization of prostate carcinoma
42. Prognostic Significance of TSC2 Expression in Diffuse Large Bcell Lymphoma
43. TSC1 Status in Diffuse Large Bcell Lymphomas
44. Comparison of Oncostatin M Expression in Keratoacanthoma and Squamous Cell Carcinoma
45. ALK Fusions in a Wide Variety of Tumor Types Respond to Anti-ALK Targeted Therapy
46. PD-L1 protein expression in tumour cells and immune cells in mismatch repair protein-deficient and -proficient colorectal cancer: the foundation study using the SP142 antibody and whole section immunohistochemistry
47. Image Processing and Analysis of Mucosal Calretinin Staining to Define the Transition Zone in Hirschsprung Disease: A Pilot Study.
48. Biomarkers of immune checkpoint inhibitor response in metastatic breast cancer: PD-L1 protein expression, CD274 gene amplification, and total mutational burden.
49. A novel histologic grading scheme based on poorly differentiated clusters is applicable to treated rectal cancer and is associated with established histopathological prognosticators
50. PD-L1 protein expression in tumour cells and immune cells in mismatch repair protein-deficient and -proficient colorectal cancer: the foundation study using the SP142 antibody and whole section immunohistochemistry.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.